J. Huang

AIDS-related Kaposi's sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee.

M. Testa, S. Krown, J. Huang, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment outcomes of percutaneous radiofrequency ablation versus adrenalectomy for adrenal metastases: a retrospective comparative study

J. Huang, H. Long, X. Xie, 2020, Journal of Endocrinological Investigation.

Is the Management of Rectal Cancer Using a Watch and Wait Approach Feasible, Safe and Effective in a Publicly Funded General Hospital?

S. Raouf, J. Huang, R. Boulton, 2021, Clinical oncology (Royal College of Radiologists (Great Britain)).

Kaposi's sarcoma and non-Hodgkin's lymphoma incidence trends in AIDS Clinical Trial Group study participants.

J. V. Von Roenn, M. Testa, J. Huang, 1999, Journal of acquired immune deficiency syndromes.

Efficacy of chemotherapy for prostatic tuberculosis-a clinical and histologic follow-up study.

Chia-Cheng Yu, J. Wang, J. Huang, 2001, Urology.

Long-term clinical and molecular remissions in patients with follicular lymphoma following high-dose therapy and autologous stem cell transplantation

Y. Luo, Y. Wu, C. Zhou, 2013 .

Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142--low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor. National Institute of Allergy and Infectious Diseas

M. Testa, L. Kaplan, A. Levine, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Final overall survival results from a randomised, phase III study of erlotinib versus chemotherapy as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer (OPTIMAL, CTONG-0802).

Y. Wu, Y. Luo, Q. Xiu, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.

J. V. Von Roenn, A. Tulpule, D. Northfelt, 1997, The New England journal of medicine.

A randomized, phase Ib/II trial of rilotumumab (AMG 102; ril) or ganitumab (AMG 479; gan) with panitumumab (pmab) versus pmab alone in patients (pts) with wild-type (WT) KRAS metastatic colorectal cancer (mCRC): Primary and biomarker analyses.

E. Van Cutsem, J. Tabernero, N. Tebbutt, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.